Clincosm LogoSign in Get a demo

t2dm (type 2 diabetes mellitus)

Showing 1 - 25 of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T2DM (Type 2 Diabetes) Trial (DWP16001 0.3 mg)

Not yet recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • DWP16001 0.3 mg
  • (no location specified)
Nov 15, 2023

T2DM (Type 2 Diabetes), Hypertension, Heart Disease Chronic Trial (Virtual Group Visit)

Not yet recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • +6 more
  • Virtual Group Visit
  • (no location specified)
Oct 17, 2023

Normoglycemia, T2DM (Type 2 Diabetes) Trial in New Delhi (Bread, Mango)

Completed
  • Normoglycemia
  • T2DM (Type 2 Diabetes Mellitus)
  • Bread
  • Mango
  • New Delhi, Delhi, India
    Fortis CDOC Hospital
Sep 20, 2023

T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)

Completed
  • T2DM (Type 2 Diabetes Mellitus)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 1, 2023

Healthy Subjects, Obesity, T2DM (Type 2 Diabetes) Trial in Changchun (HEC88473 injection, Placebo)

Completed
  • Healthy Subjects
  • +2 more
  • HEC88473 injection
  • Placebo
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jul 14, 2023

T2DM (Type 2 Diabetes) Trial in Nanjing (Ecnoglutide, Placebo)

Not yet recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • Nanjing, Jiangsu, China
    Nanjing Drum Tower Hospital
Jan 10, 2023

T2DM (Type 2 Diabetes) Trial in Shanghai (Ecnoglutide high dosage, Ecnoglutide low dosage, Dulaglutide)

Not yet recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • Ecnoglutide high dosage
  • +3 more
  • Shanghai, Shanghai, China
    ZHONGSHAN Hospital
Dec 25, 2022

T2DM (Type 2 Diabetes) Trial in Flint (Cohort A: ORMD-0801, Placebo oral capsule, Cohort B: ORMD-0801)

Completed
Has Results
  • T2DM (Type 2 Diabetes Mellitus)
  • Cohort A: ORMD-0801
  • +2 more
  • Flint, Michigan
    AA MRC
Nov 6, 2022

T2DM (Type 2 Diabetes) Trial in Seoul (DWP16001 Amg)

Completed
  • T2DM (Type 2 Diabetes Mellitus)
  • DWP16001 Amg
  • Seoul, Korea, Republic of
    Daewoong pharmatceutical
Oct 23, 2022

T2DM (Type 2 Diabetes) Trial in Seoul (DWP16001)

Completed
  • T2DM (Type 2 Diabetes Mellitus)
  • Seoul, Korea, Republic of
    Daewoong pharmatceutical
Oct 23, 2022

Type2 Diabetes, Diabetes, Diabetes, Type 2 Trial in Worldwide (Tirzepatide Dose 1, Tirzepatide Dose 2, Placebo)

Recruiting
  • Type2 Diabetes
  • +7 more
  • Tirzepatide Dose 1
  • +2 more
  • Birmingham, Alabama
  • +55 more
Aug 8, 2022

T2DM (Type 2 Diabetes), Metformin, SGLT2-Inhibitors Trial in Matsumoto (Tofogliflozin, Metformin)

Recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • +2 more
  • Matsumoto, Nagano, Japan
    Shinshu University
Jul 21, 2022

T2DM (Type 2 Diabetes) Trial in Hangzhou (THR-1442 20mg Single dose, THR-1442 20mg Multiple dose group)

Recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • THR-1442 20mg Single dose
  • THR-1442 20mg Multiple dose group
  • Hangzhou, Zhejiang, China
    Hangzhou First People's hospital
May 5, 2022

T2DM (Type 2 Diabetes) Trial in Coral Gables (ORMD-0801, Placebo)

Recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • Coral Gables, Florida
    Research Institute of South Florida, Inc. (PHARMASEEK)
Apr 11, 2022

T2DM (Type 2 Diabetes) Trial in Bucheon (DWP16001 Amg)

Completed
  • T2DM (Type 2 Diabetes Mellitus)
  • DWP16001 Amg
  • Bucheon, Korea, Republic of
    The Catholic University of Korea Bucheon St. Mary's Hospital, Re
Mar 30, 2022

T2DM (Type 2 Diabetes), Low-level Laser Therapy, Bone Density Increased Trial in Cairo, El-Arish, Gamasa (low-level laser

Completed
  • T2DM (Type 2 Diabetes Mellitus)
  • +2 more
  • low-level laser therapy (LLLT)
  • Cairo, Egypt
  • +4 more
Mar 5, 2022

T2DM (Type 2 Diabetes), Diet, Healthy, Renal Function Disorder Trial in Milano (Sulfa-zero: possible benefits of the treatment

Recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • +3 more
  • Sulfa-zero: possible benefits of the treatment of new generation hypoglycaemic drugs compared to sulphonylureas
  • Milano, Italy
    ASST FBF-Sacco P.O. Sacco/Fatebenefratelli e Oftalmico
Sep 27, 2021

T2DM (Type 2 Diabetes), Needle-free Injector, Time in Range Trial in China (Needle-free injector, Insulin pen)

Recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • +2 more
  • Needle-free injector
  • Insulin pen
  • Changxing, Zhejiang, China
  • +20 more
Aug 30, 2021

T2DM (Type 2 Diabetes) Trial in Jeonju (Treatment A, Treatment B, Treatment C)

Completed
  • T2DM (Type 2 Diabetes Mellitus)
  • Treatment A
  • +2 more
  • Jeonju, Korea, Korea, Republic of
    Min-gul Kim
Jul 12, 2021

Atrial Fibrillation, T2DM (Type 2 Diabetes), Chronic Kidney Diseases Trial in Moscow (Dabigatran Etexilate)

Recruiting
  • Atrial Fibrillation
  • +2 more
  • Dabigatran Etexilate
  • Moscow, Russian Federation
    I.M.Sechenov First Moscow State Medical University (Sechenov Uni
Mar 23, 2021

Nutritional Therapy for Diabetic Cardiomyopathy

Completed
  • T2DM (Type 2 Diabetes Mellitus)
    • Saint Louis, Missouri
      Washington University School of Medicine
    Feb 9, 2021

    Pre-diabetes, Cardiovascular Risk Factor, T2DM (Type 2 Diabetes) Trial in Akureyri (Guided Self Determination)

    Recruiting
    • Pre-diabetes
    • +3 more
    • Guided Self Determination
    • Akureyri, Iceland
      University of Akureyri
    Jan 27, 2021

    T2DM (Type 2 Diabetes) Trial in Seoul (CKD-501, D759, D150, CKD-393 0.5/100/1000 mg)

    Not yet recruiting
    • T2DM (Type 2 Diabetes Mellitus)
    • CKD-501, D759, D150
    • CKD-393 0.5/100/1000 mg
    • Seoul, Korea, Republic of
      Severance Hospital
    Jan 10, 2021

    T2DM (Type 2 Diabetes) Trial in Soeul (Dapagliflozin)

    Recruiting
    • T2DM (Type 2 Diabetes Mellitus)
    • Soeul, Korea, Republic of
      Daewoong pharmatceutical
    Nov 18, 2020

    T2DM (Type 2 Diabetes) Trial in Seoul (DWP16001)

    Enrolling by invitation
    • T2DM (Type 2 Diabetes Mellitus)
    • Seoul, Korea, Republic of
      Daewoong pharmatceutical
    Nov 12, 2020